Prior to founding YH2 Capital, Yen How Tai was an entrepreneur and investor.

As a big believer of giving back to the community and in his continuous efforts to make an impact to the world, Yen co-founded Citrin Foundation in 2016 together with Barbara as part of their hands-on approach to philanthropy. Citrin Foundation is a patient-driven, not-for-profit organization aiming to tackle a medical condition known as citrin deficiency. Seeking to work with top scientists, researchers, and physicians who are in the related fields around the world, the Foundation aims to learn more about the condition, find effective treatments and eventually find a cure.

Yen graduated from Harvard University with a BA in Economics. Yen was an ASEAN Scholar.

Previous roles

In 1999, he founded an online real estate company and grew it to be the biggest online property business in Hong Kong. After selling the business, Yen branched out into real estate investment and development in Shanghai, Beijing, Hong Kong and Singapore.

Before becoming an entrepreneur, Yen worked at Investor AB’s private equity arm in Asia. Yen started his career as a management consultant at McKinsey & Company’s Greater China office, where he advised governments and leading multinational corporations in China, Japan and Southeast Asia, in the telecommunications, consumer products, information technology, government policies and retail sectors.

Before founding YH2 Capital, Barbara Yu was the Head of Asia of Eton Park Capital Management from 2006 to 2010 and was responsible for Eton Park’s public and private investments in Asia. Prior to that, Barbara was Head of Principal Strategies Group in Goldman Sachs in Hong Kong.

As a big believer of giving back to the community and in her continuous efforts to make an impact to the world, Barbara co-founded Citrin Foundation in 2016 together with Yen as part of their hands-on approach to philanthropy. Citrin Foundation is a patient-driven, not-for-profit organization aiming to tackle a medical condition known as citrin deficiency. Seeking to work with top scientists, researchers, and physicians who are in the related fields around the world, the Foundation aims to learn more about the condition, find effective treatments and eventually find a cure.

Barbara graduated from Magdalene College, Cambridge University, with a BA in Law, double first-class honors. Barbara was awarded the N. Diaz Scholarship for Law and Norton Rose Prize for Commercial Law. She was also a Jardine Scholar which provided a full scholarship for her undergraduate study.

Previous roles

Barbara started her career at Morgan Stanley in New York and Hong Kong, where she focused on mergers, acquisitions and restructuring. She then spent five years at Goldman Sachs in Hong Kong where she rose to the position of the Head of the firm’s Principal Strategies Group in the Asia Pacific region. The Group encompassed the proprietary investing business of the equities division at Goldman.

Following that, Barbara spent five years at Eton Park Capital Management, a global, multi-disciplinary investment organization with approximately US$10 billion of assets under management. In her role, Barbara founded, built and managed the Asia investment business of Eton Park.